Share on StockTwits

Flamel Technologies S.A. (NASDAQ:FLML) was downgraded by Zacks from an “outperform” rating to a “neutral” rating in a report released on Wednesday. They currently have a $16.20 target price on the stock. Zacks‘s price objective suggests a potential upside of 18.16% from the stock’s previous close.

Flamel Technologies S.A. (NASDAQ:FLML) traded up 2.99% during mid-day trading on Wednesday, hitting $14.12. 36,676 shares of the company’s stock traded hands. Flamel Technologies S.A. has a 1-year low of $5.30 and a 1-year high of $15.75. The stock’s 50-day moving average is $14.19 and its 200-day moving average is $12.14. The company’s market cap is $540.3 million.

Flamel Technologies S.A. (NASDAQ:FLML) last released its earnings data on Tuesday, July 29th. The company reported ($0.13) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.08) by $0.05. The company had revenue of $8.10 million for the quarter, compared to the consensus estimate of $9.92 million. During the same quarter last year, the company posted ($1.29) earnings per share. Analysts expect that Flamel Technologies S.A. will post $-0.28 EPS for the current fiscal year.

Separately, analysts at Leerink Swann initiated coverage on shares of Flamel Technologies S.A. in a research note on Friday, August 1st. They set an “outperform” rating and a $22.00 price target on the stock. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $17.90.

Flamel Technologies SA has a pipeline of niche specialty pharmaceutical products. The Company’s drug delivery platforms are focused on developing safer, more efficacious formulations of drugs to address unmet medical needs.

To view Zacks’ full report, visit Zacks’ official website.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.